1. Home
  2. CSTL vs MBUU Comparison

CSTL vs MBUU Comparison

Compare CSTL & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$21.05

Market Cap

611.1M

Sector

Health Care

ML Signal

HOLD

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

HOLD

Current Price

$27.41

Market Cap

541.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
MBUU
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
611.1M
541.4M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
CSTL
MBUU
Price
$21.05
$27.41
Analyst Decision
Strong Buy
Hold
Analyst Count
6
5
Target Price
$45.50
$32.20
AVG Volume (30 Days)
468.8K
320.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
127.74
EPS
N/A
N/A
Revenue
$344,229,000.00
$807,561,000.00
Revenue This Year
$2.42
$2.14
Revenue Next Year
$12.69
$12.78
P/E Ratio
N/A
N/A
Revenue Growth
3.66
N/A
52 Week Low
$14.59
$23.84
52 Week High
$44.28
$39.65

Technical Indicators

Market Signals
Indicator
CSTL
MBUU
Relative Strength Index (RSI) 47.27 52.78
Support Level $17.72 $24.24
Resistance Level $24.46 $27.60
Average True Range (ATR) 1.12 1.35
MACD 0.37 0.10
Stochastic Oscillator 74.65 45.46

Price Performance

Historical Comparison
CSTL
MBUU

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Most recently, in 2026, it tied up with Saxdor Yachts, focused on adventure dayboats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

Share on Social Networks: